CS logo
small CS logo
Pacific Cancer Care

Monterey, California, United States
Cancer treatment center in Monterey, California
5 Harris Ct Building T Suite 201, Monterey, CA 93940

About Pacific Cancer Care


"The highly qualified physicians and staff at Pacific Cancer Care work diligently to provide our patients & family members with a comfortable and caring environment while delivering high quality personalized care. Everything we do at PCC is designed with our patients' in mind."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
SWOG Cancer Research Network
5
Oncotherapeutics
4
Bristol-Myers Squibb
2
Celgene
2
Daiichi Sankyo, Inc.
2
Dana-Farber Cancer Institute
2
National Cancer Institute (NCI)
2
Amgen
1
Aptose Biosciences Inc.
1
Astellas Pharma Global Development, Inc.
1
Total Rows: 28

Clinical Trials at Pacific Cancer Care


During the past decade, Pacific Cancer Care conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 16 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22005533440011330011331133113333Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
2001-01-01
Unknown status
Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
2005-09-01
2009-06-01
Completed
247
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
2006-01-01
2007-11-01
Terminated
1,200
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
2008-09-01
2012-01-01
Terminated
415
Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
2009-03-11
2015-04-30
Completed
119
Connect® MM- The Multiple Myeloma Disease Registry
2009-09-01
2024-12-31
Active, not recruiting
3,011
Phase 1 and 2 Study of PX-866 and Cetuximab
2010-12-01
2014-01-01
Completed
178
Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
2011-05-01
2015-12-01
Completed
160

Rows per page:

1–44 of 44

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Pacific Cancer Care" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Oncotherapeutics" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Blood Cancer Research Partnership" with 2 trials as a collaborator, "The Leukemia and Lymphoma Society" with 2 trials as a collaborator and "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 5Eli Lilly and Company: 5SWOG Cancer ResearchNetwork: 5SWOG Cancer ResearchNetwork: 5Oncotherapeutics: 4Oncotherapeutics: 4Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Celgene: 2Celgene: 2Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2Dana-Farber Cancer Institute: 2Dana-Farber Cancer Institute: 2National Cancer Institute (NCI): 2National Cancer Institute (NCI): 2Amgen: 1Amgen: 1Aptose Biosciences Inc.: 1Aptose Biosciences Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 5National Cancer Institute (NCI): 5AstraZeneca: 2AstraZeneca: 2Blood Cancer ResearchPartnership: 2Blood Cancer ResearchPartnership: 2The Leukemia andLymphoma Society: 2The Leukemia andLymphoma Society: 2Academic GI CancerConsortium (AGICC): 1Academic GI CancerConsortium (AGICC): 1Amgen: 1Amgen: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Celgene Corporation: 1Celgene Corporation: 1Daiichi Sankyo Co., Ltd.: 1Daiichi Sankyo Co., Ltd.: 1Incyte Corporation: 1Incyte Corporation: 1

Clinical Trials Conditions at Pacific Cancer Care


According to Clinical.Site data, the most researched conditions in "Pacific Cancer Care" are "Multiple Myeloma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Pacific Cancer Care" in a lesser frequency.

Clinical Trials Intervention Types at Pacific Cancer Care


Most popular intervention types in "Pacific Cancer Care" are "Drug" (39 trials), "Other" (8 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Abemaciclib" (4 trials), "Dexamethasone" (4 trials), "Nivolumab" (4 trials) and "Palbociclib" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Pacific Cancer Care


The vast majority of trials in "Pacific Cancer Care" are 39 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Pacific Cancer Care


Currently, there are NaN active trials in "Pacific Cancer Care". undefined are not yet recruiting, 7 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Pacific Cancer Care, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Pacific Cancer Care, 9 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 20Phase 2: 20Phase 3: 16Phase 3: 16Phase 1: 9Phase 1: 9Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 12Active, not recruiting: 12Completed: 12Completed: 12Recruiting: 7Recruiting: 7Terminated: 7Terminated: 7Unknown status: 3Unknown status: 3Approved for marketing: 1Approved for marketing: 1No longer available: 1No longer available: 1Withdrawn: 1Withdrawn: 1